BIOMAT Database Logo BIOMAT Database Logo

CoMFA and CoMSIA studies on HIV-1 attachment inhibitors. 2010

Peng Lu, and Xia Wei, and Ruisheng Zhang
College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, Gansu, PR China. larvap07@gmail.com

A series of human immunodeficiency virus type 1 (HIV-1) attachment inhibitors were subjected to ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) studies using the comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) approaches. The CoMFA model yielded satisfactory statistical data with the cross-validated q2 value of 0.589 and the non-cross-validated r2 value of 0.963. The cross-validated q2 value of CoMSIA Model was 0.621 and the non-cross-validated r2 value was 0.972. From the cross-validated results, it can be seen that the CoMSIA model has a better predictive ability than CoMFA model. Based on the above results, the CoMFA and CoMSIA analyses can be used in the design of more potent HIV-1 attachment inhibitors.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D021281 Quantitative Structure-Activity Relationship A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. Structure Activity Relationship, Quantitative,3D-QSAR,QSAR,QSPR Modeling,Quantitative Structure Property Relationship,3D QSAR,3D-QSARs,Modeling, QSPR,Quantitative Structure Activity Relationship,Quantitative Structure-Activity Relationships,Relationship, Quantitative Structure-Activity,Relationships, Quantitative Structure-Activity,Structure-Activity Relationship, Quantitative,Structure-Activity Relationships, Quantitative

Related Publications

Peng Lu, and Xia Wei, and Ruisheng Zhang
CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors.
September 2013, Current computer-aided drug design,
Peng Lu, and Xia Wei, and Ruisheng Zhang
CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents.
February 2009, Journal of molecular graphics & modelling,
Peng Lu, and Xia Wei, and Ruisheng Zhang
3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors.
November 2017, Recent patents on anti-cancer drug discovery,
Peng Lu, and Xia Wei, and Ruisheng Zhang
3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors.
December 2008, Bioorganic & medicinal chemistry letters,
Peng Lu, and Xia Wei, and Ruisheng Zhang
HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: SAR and Lead Optimization Using CoMFA and CoMSIA Studies (1995-2016).
November 2017, Current medicinal chemistry,
Peng Lu, and Xia Wei, and Ruisheng Zhang
Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses.
July 2009, Journal of molecular modeling,
Peng Lu, and Xia Wei, and Ruisheng Zhang
Three-dimensional quantitative structure: activity relationship studies on diverse structural classes of HIV-1 integrase inhibitors using CoMFA and CoMSIA.
December 2006, European journal of medicinal chemistry,
Peng Lu, and Xia Wei, and Ruisheng Zhang
CoMFA and CoMSIA studies on fluorinated hexahydropyrimidine derivatives.
December 2011, Bioorganic & medicinal chemistry letters,
Peng Lu, and Xia Wei, and Ruisheng Zhang
Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
January 2004, Journal of medicinal chemistry,
Peng Lu, and Xia Wei, and Ruisheng Zhang
Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses.
May 2009, European journal of medicinal chemistry,
Copied contents to your clipboard!